AICEP | Romania

📢 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗮𝗿𝗲 𝘀𝗲𝘁𝘁𝗶𝗻𝗴 𝘁𝗵𝗲𝗶𝗿 𝘀𝗶𝗴𝗵𝘁𝘀 𝗼𝗻 𝗣𝗼𝗿𝘁𝘂𝗴𝗮𝗹! Don't miss out on the latest buzz in foreign investment. In the September newsletter, we highlight new investments from:  • Mantu 🇨🇭 • DACHSER 🇩🇪 • FunPlus 🇨🇭 • Allianz 🇩🇪 • WEG 🇧🇷 • Cloudflare 🇺🇸 Our newsletter includes exclusive insights, exciting updates, and key monthly highlights. 🌟 Whether you're an investor, business enthusiast, or just curious about global market trends, this newsletter is a must-read! Subscribe now ➡️ https://lnkd.in/g42SwRAT

🚲🇵🇹 Cycling, a sustainable and health-conscious transport option, remains a focus of European manufacturing. Portugal was the largest producer for two consecutive years, with 1.8 million bicycles manufactured, followed by Romania 🇷🇴, Italy, and Poland. Although most EU countries experienced production decreases, Portugal continues to play a vital role in the sector, highlighting its manufacturing expertise. Let's continue championing innovation and sustainability in this key industry. Know more 👉 https://lnkd.in/gCNAHbkZ

🌍 Good news! Parques de Sintra has been awarded for the second consecutive year with "World's Best Cultural Destination" at the World Luxury Travel Awards 2024! 🏆 This prestigious recognition highlights the exceptional dedication to preserving and promoting Portugal's rich cultural heritage. 🇵🇹 Parques de Sintra encompasses several UNESCO World Heritage sites, including the iconic Pena Palace, the romantic gardens of Monserrate, and the mystic forests of the Sintra Mountains 🏰🌲. This recognition strengthens Portugal's global image, demonstrating the country's commitment to heritage, sustainability, and high standards, all essential factors in drawing international attention and fostering economic growth. 💼 🔗 Know more: https://lnkd.in/diqjRji9 #AICEP #Sintra #CulturalTourism #PortugueseHeritage #ParquesdeSintra #WorldTravelAwards #InvestmentInPortugal

🎉 Join us congratulating BIAL 🇵🇹 on its 𝟭𝟬𝟬𝘁𝗵 𝗕𝗶𝗿𝘁𝗵𝗱𝗮𝘆 and as it continues to bring innovative medicines to the world! 🌍 🌎 🌏   ⚕ 💊 The two driving forces behind BIAL´s international expansion are 𝑍𝑒𝑏𝑖𝑛𝑖𝑥 and 𝑂𝑛𝑔𝑒𝑛𝑡𝑦𝑠. The first is an anti-epileptic drug launched in 2009 and the second is a Parkinson's disease drug launched in 2016. Without them, the company would not have reached more than 50 international markets or generated €340 million in sales in 2023. Around 20% of the company's turnover is spent on research and development because its "goal is to continue to bring innovative medicines to people". This year, #BIAL celebrates its centenary, and more than just a symbolic date, it marks the journey and evolution of a company that began as a small laboratory in the centre of Porto 🇵🇹. A journey that began with the launch of the first two patented medicines in Portugal 🇵🇹. Today, BIAL has subsidiaries in the main European markets 🇪🇺 and in the United States 🇺🇸. Over the years, the company has sought to respond to its challenges, and António Portela cites sustainability issues as an example. "These are inevitable in our society, in our world, and at BIAL this is no exception". 🔗 Read the full article ⬇ https://lnkd.in/dktuev49   #Innovation #Medine #PharmaceuticalIndustry #MadeInPortugal #BuyFromPortugal #InvestInPortugal #BusinessMatchMaking #PortugalOpenForBusiness #AICEP By AICEP | Malaysia

🎗️💊 With a solid commitment to innovation, Bluepharma has evolved from providing generic medicines to becoming a key player in advanced and complex therapeutics. Recognised globally, the company operates in over 40 countries and recently inaugurated one of Europe's largest oncology manufacturing units in Coimbra. 🏭 📈 Bluepharma's strategic focus on oncology and high-tech injectables highlights its role in shaping cutting-edge therapeutic solutions. With 87% of its exports, the company targets robust growth in international markets like the United States. 🌍 In line with its mission to revolutionise healthcare, Bluepharma has partnered with academia and invested in Coimbra Life Sciences Park and CInTech to establish Portugal's first technology centre for complex injectables. These efforts underline its dedication to innovation and global healthcare excellence. 🧪 🔗 Read the full article here 👉 https://lnkd.in/d5PZGMzg

🇵🇹🚀 #AICEP President Ricardo Arroja highlighted Portugal's sustainable growth at the prestigious Financial Times event "𝘛𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘪𝘯𝘨 𝘗𝘰𝘳𝘵𝘶𝘨𝘢𝘭'𝘴 𝘌𝘤𝘰𝘯𝘰𝘮𝘺 𝘛𝘩𝘳𝘰𝘶𝘨𝘩 𝘚𝘶𝘴𝘵𝘢𝘪𝘯𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘢𝘯𝘥 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯" in partnership with Tabaqueira at the Vandelli Botanical Garden in Lisbon. Participating in the panel "𝘞𝘰𝘳𝘬𝘪𝘯𝘨 𝘵𝘰𝘨𝘦𝘵𝘩𝘦𝘳 𝘵𝘰 𝘥𝘳𝘪𝘷𝘦 𝘴𝘶𝘴𝘵𝘢𝘪𝘯𝘢𝘣𝘭𝘦 𝘨𝘳𝘰𝘸𝘵𝘩", Ricardo Arroja emphasised the crucial role of collaboration 🤝 between policymakers and industry leaders in achieving sustainable economic transformation. "AICEP actively works to position Portugal as a green hub with a dual focus: attracting green investment and promoting sustainable exports. For instance, we have the #ESG Exporting SMEs Programme that supports companies to integrate ESG - Environmental, Social, and Governance demands in their activity", said AICEP's President. 🇵🇹 "Indeed, AICEP is committed to integrating sustainability into every aspect of its operations, from investment promotion to export support, encouraging businesses, investors, and stakeholders to collaborate in building a sustainable and prosperous future for Portugal" concludes. The conference highlighted how industries are reshaping through sustainability, showcasing how addressing environmental and social impacts across the value chain can unlock innovation, drive efficiency, and foster long-term economic prosperity💡📈. Critical discussions explored the alignment of investment strategies with ESG objectives and the integration of emerging technologies to create value and scale solutions across sectors. Portugal's commitment to sustainability and innovation was in the spotlight, reinforcing the nation's position as a hub for forward-thinking investment and business practices. AICEP continues to work alongside global and national stakeholders 🌐 to ensure that Portugal thrives as a leader in sustainable growth and innovation. #Sustainability #Innovation #Portugal #EconomicGrowth #AICEP

🇵🇹 📈 𝗧𝗵𝗲 European Commission 𝗽𝗿𝗼𝗷𝗲𝗰𝘁𝘀 𝗣𝗼𝗿𝘁𝘂𝗴𝗮𝗹'𝘀 𝗚𝗗𝗣 𝘁𝗼 𝗴𝗿𝗼𝘄 𝗯𝘆 𝟭.𝟳% 𝗶𝗻 𝟮𝟬𝟮𝟰, 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗲𝗱 𝗯𝘆 𝗽𝗿𝗶𝘃𝗮𝘁𝗲 𝗰𝗼𝗻𝘀𝘂𝗺𝗽𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁. 📊 Growth is expected to reach 2.1% by 2026, reflecting a steady recovery. Inflation is forecast to continue slowing, boosting purchasing power 💶, while unemployment will slightly decline, stabilising at 6.2% by 2026. This optimistic yet measured outlook underscores Portugal's resilience and commitment to sustainable progress. Learn more about Portugal's economic forecast here 👉 https://lnkd.in/gPv6aHuQ

No dia 04 de dezembro, o fórum MARKET DAYS vai debruçar-se sobre a potencialidade de mercados (geográficos e industriais) emergentes para a indústria de moldes. 🌍✈ Programa completo: https://lnkd.in/dx3iMiRk Não fique de fora do debate. Inscreva-se agora! #CEFAMOL #FórumMarketDays #PromoçãoInternacional #IndústriadeMoldes

💊 📈 Celebrating nearly 250 years of history, Grupo Azevedos exemplifies Portugal's leadership in pharmaceutical innovation. Operating across 80 countries, with advanced manufacturing capabilities, the group is a pioneer in Industry 4.0 and lyophilisation technology—key for producing injectable medications with unparalleled precision. As the largest pharmaceutical company in Mozambique and a major exporter of Portuguese medicines (90% of production), Grupo Azevedos leverages cutting-edge automation and artificial intelligence to ensure high-quality, efficient production. With ambitious plans, including entering the US market by 2026 and achieving a fully digitalised factory by the end of the decade, the group continues to set benchmarks in quality and innovation. Grupo Azevedos' unwavering commitment to "making quality medicines" not only reinforces its global presence but also elevates Portugal's standing as a pharmaceutical powerhouse. Read the full article here 👉 https://lnkd.in/d8hnpkfg #InvestInPortugal #GrupoAzevedos #PharmaInnovation #PortugueseExcellence #AICEP

🇵🇹🤝🇺🇸 Dextall, an innovative US-based company specialising in sustainable and modular construction, is investing €10 million in Portugal. This strategic move establishes Portugal as the hub for its European expansion, with plans to develop a state-of-the-art manufacturing unit. The facility will focus on producing advanced modular façade solutions, aligning with Dextall's mission to revolutionise the construction industry through energy efficiency and eco-friendly practices. This investment highlights Portugal's growing appeal as a destination for foreign direct investment, driven by its skilled workforce, strategic location, and commitment to innovation. Learn more 👉 https://lnkd.in/dmMG3npQ #Portugal #Investment #Sustainability #Innovation #AICEP